|
Volumn 27, Issue 3, 2002, Pages 133-134
|
Head and neck cancer: A screening strategy
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
INTEGRIN;
TOLONIUM CHLORIDE;
BREAST CARCINOMA;
CANCER DIAGNOSIS;
CANCER LOCALIZATION;
CANCER RISK;
CANCER SCREENING;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL FEATURE;
CORRELATION ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
DISEASE COURSE;
DNA CONTENT;
EDITORIAL;
HEAD AND NECK CARCINOMA;
HIGH RISK POPULATION;
HOARSENESS;
HUMAN;
HYPOPHARYNX CARCINOMA;
MEDICAL SPECIALIST;
NASOPHARYNX CARCINOMA;
NEEDLE BIOPSY;
NOSE CARCINOMA;
ONCOGENE;
OROPHARYNX CARCINOMA;
PREDICTION;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN EXPRESSION;
RISK ASSESSMENT;
RISK FACTOR;
SOCIOECONOMICS;
SURVIVAL RATE;
TREATMENT PLANNING;
ULTRASOUND;
UNITED KINGDOM;
AGE FACTORS;
ALCOHOL DRINKING;
COST-BENEFIT ANALYSIS;
HEAD AND NECK NEOPLASMS;
HEALTH CARE COSTS;
HUMANS;
MASS SCREENING;
RISK;
SMOKING;
|
EID: 0036064141
PISSN: 03077772
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2273.2002.00547.x Document Type: Editorial |
Times cited : (5)
|
References (19)
|